Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02568787 · ClinicalTrials.gov registry record · NA
The Effect of an RBAC Supplement (BRM4) on NAFLD
A NA study of Non-alcoholic Fatty Liver Disease, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT02568787 is a NA study of Non-alcoholic Fatty Liver Disease that has completed, run by University of Miami. The registered enrollment target is 23 participants, below the 190-participant average among 50 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02568787, a NA study of Non-alcoholic Fatty Liver Disease, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the effects of Rice Bran Arabinoxylan Compound (RBAC) on outcome variables in persons with non-alcoholic fatty liver disease (NAFLD). This nutritional supplement is made from a water soluble extract of rice bran that has been partially hydrolyzed by the action of a natural enzyme complex extracted from Shiitake mushroom.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT rice bran arabinoxylan compound (RBAC)
Study Locations (1)
Florida
- University of Miami Miller School of Medicine, Soffer Clinical Research Center, Department of Psychiatry & Behavioral Sciences - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-06-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02568787
The ClinicalTrials.gov registry entry for NCT02568787 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 50 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (88% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-alcoholic Fatty Liver Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02568787 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02568787 about?
NCT02568787 is a clinical study titled "The Effect of an RBAC Supplement (BRM4) on NAFLD". The purpose of this study is to investigate the effects of Rice Bran Arabinoxylan Compound (RBAC) on outcome variables in persons with non-alcoholic fatty liver disease (NAFLD). This nutritional supplement is made from a water soluble extract of rice bran that has been partially hydrolyzed by the ac...
What is the current status of trial NCT02568787?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2016-05. Estimated completion is 2017-06-10.
What conditions does trial NCT02568787 study?
This clinical trial studies the following conditions: Non-alcoholic Fatty Liver Disease.
What interventions are being tested in trial NCT02568787?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), rice bran arabinoxylan compound (RBAC) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02568787?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02568787 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-alcoholic Fatty Liver Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intermittent Fasting for NAFLD in Adults
RECRUITING · NA
-
Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents
RECRUITING · NA
-
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
RECRUITING · NA
-
The Olmsted NAFLD Epidemiology Study (TONES)
RECRUITING · NA
-
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
RECRUITING · NA
-
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.